The activation of STAT3 has been known to cause malignancies, such as hepatocellular carcinoma (He et al., 2013; Ohishi et al., 2014), lung cancer (Songür et al., 2004), and breast cancer (Salgado et al., 2003). This evidence concerns the gene STAT3 and breast carcinoma.